Clinical Trial Update: Clinical Validation of Immunovia Next-Generation Blood Biomarker Test to Detect Early-Stage Pancreatic Cancer

View source ↗

Summary

This completed clinical trial validates Immunovia's next-generation blood biomarker test for detecting pancreatic cancer at early stages.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Pancreatic Cancer
• Pancreatic Ductal Adenocarcinoma

Snippet

Sponsor: Immunovia, Inc. | Conditions: Pancreatic Cancer Stage I, Pancreatic Cancer Stage II | Status: COMPLETED